Ophthalmic drug delivery system
First Claim
1. A drug delivery system comprising a contact lens having dispersed therein as nanoparticles having a particle size less than about 50 nm, an ophthalmic drug nanoencapsulated in a material from which said ophthalmic drug is capable of diffusion into and migration through said contact lens and into the post-lens tear film when said contact lens is placed on the eye, said nanoparticles being dispersed within said contact lens in an amount such that said lens remains substantially optically transparent.
2 Assignments
0 Petitions
Accused Products
Abstract
A drug delivery system comprising a contact lens having dispersed therein as nanoparticles having a particle size less than about 50 nm, an ophthalmic drug nanoencapsulated in a material from which said ophthalmic drug is capable of diffusion into and migration through said contact lens and into the post-lens tear film when said contact lens is placed on the eye.
-
Citations
11 Claims
- 1. A drug delivery system comprising a contact lens having dispersed therein as nanoparticles having a particle size less than about 50 nm, an ophthalmic drug nanoencapsulated in a material from which said ophthalmic drug is capable of diffusion into and migration through said contact lens and into the post-lens tear film when said contact lens is placed on the eye, said nanoparticles being dispersed within said contact lens in an amount such that said lens remains substantially optically transparent.
-
7. An article of manufacture comprising packaging material and the ophthalmic drug delivery system contained within said packaging material, said ophthalmic drug delivery system comprising a contact lens having dispersed therein as nanoparticles having a particle size less than about 50 nm, an ophthalmic drug nanoencapsulated in a material from which said ophthalmic drug is capable of diffusion into and migration through said contact lens and into the post-lens tear film when said contact lens is placed on the eye, said nanoparticles being dispersed within said contact lens in an amount such that said lens remains substantially optically transparent, wherein said packaging material further includes a label which indicates that said ophthalmic drug delivery system can be used for ameliorating symptoms associated with pathologic conditions of the eye.
Specification